Biomarin articles
-
Primecap Management Co. CA Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Primecap Management Co. CA lifted its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,414,374 shares of the biotechnology company’s stock after purchasing an additional 7,835 shares during the quarter. BioMarin Pharmaceutical […]